Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up.
Clonazepam in the treatment of panic disorder and agoraphobia: a one-year follow-up.
复制标题
氯硝西泮治疗恐慌症和广场恐惧症：一年随访。
DOI：
--
复制
发表时间：
1986
影响因子：
2.9
通讯作者：
S. Spier
中科院分区：
文献类型：
--
作者：
M. Pollack;G. Tesar;J. Rosenbaum;S. Spier
50例惊恐障碍或广场恐怖症伴惊恐发作的患者使用高效苯二氮卓类药物氯硝西潘治疗。作者报告了这些患者在平均随访1年后的结果，表明在相对治疗难治的患有恐慌症和广场恐惧症的非抑郁症患者中，氯硝西潘是一种安全、有效和易于管理的药物。
Fifty patients with panic disorder or agoraphobia with panic attacks with treated with clonazepam, a high potency benzodiazepine. The authors report on the outcome of these patients after an average follow-up interval of 1 year, suggesting that clonazepam is a safe, effective, and easy to administer medication in a relatively treatment-refractory population of nondepressed patients with panic disorder and agoraphobia.